This provider's $29.1M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 1036% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 117% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $274.58 | $39.73 | 6.91x | $234.85 | $537.3K | 13.5K | 14 |
| 2015 | $260.00 | $52.55 | 4.95x | $207.45 | $762.3K | 14.5K | 19 |
| 2016 | $356.54 | $74.30 | 4.80x | $282.24 | $1.6M | 20.9K | 18 |
| 2017 | $417.04 | $85.89 | 4.86x | $331.15 | $1.8M | 20.9K | 18 |
| 2018 | $441.57 | $92.47 | 4.78x | $349.10 | $2.1M | 22.6K | 21 |
| 2019 | $414.91 | $87.99 | 4.72x | $326.92 | $2.4M | 27.0K | 28 |
| 2020 | $274.83 | $74.08 | 3.71x | $200.75 | $2.2M | 29.9K | 25 |
| 2021 | $136.25 | $49.15 | 2.77x | $87.10 | $4.8M | 97.8K | 33 |
| 2022 | $140.44 | $47.38 | 2.96x | $93.06 | $6.8M | 144.5K | 39 |
| 2023 | $177.21 | $72.30 | 2.45x | $104.91 | $6.1M | 84.4K | 41 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 68.1K | $5.2M | $75.63 | 3.25x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 79.7K | $3.9M | $48.47 | 5.42x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 22.5K | $3.1M | $139.78 | 1.43x |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 8.0K | $2.7M | $342.44 | 7.19x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 54.3K | $1.9M | $34.94 | 1.14x |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | 19.3K | $1.6M | $80.41 | 4.69x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 60.8K | $1.5M | $24.70 | 2.02x |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | 8.5K | $1.3M | $154.67 | 2.70x |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | 18.2K | $1.1M | $62.94 | 4.52x |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 38.8K | $977.8K | $25.19 | 1.98x |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | 16.7K | $952.5K | $56.87 | 4.72x |
| 88121 | Cell examination of urine, computer-assisted | 2.2K | $736.0K | $334.23 | 2.93x |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 9.5K | $669.2K | $70.26 | 1.23x |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | 5.9K | $510.3K | $86.23 | 4.25x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 13.0K | $454.0K | $34.81 | 1.12x |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | 5.5K | $432.7K | $78.54 | 3.71x |
| 87507 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets | 773 | $389.9K | $504.42 | 2.28x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12.7K | $292.1K | $22.99 | 2.17x |
| 0097U | Test for detection of gastrointestinal disease-causing organism using amplified probe | 460 | $165.7K | $360.33 | 3.89x |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 4.1K | $141.8K | $34.96 | 1.58x |
This provider submits charges 3.49 times higher than what Medicare actually pays.
A markup ratio of 3.49x means for every $100 Medicare pays, this provider initially charges $349. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data